Direct Meds Partners with Hum Capital to Fund Organic Growth and Acquisitions

Direct Meds Partners with Hum Capital to Fund Organic Growth and Acquisitions

Direct Meds, a rapidly growing direct-to-consumer telehealth platform, has partnered with Hum Capital on a $6,000,000 growth capital facility. The financing supports the company’s continued organic growth alongside an acquisition strategy.

The Challenge

Telehealth is one of the fastest-growing corners of consumer healthcare — and one of the least legible to traditional lenders.

Revenue is subscription-adjacent, and customer acquisition is front-loaded. Cohort retention, refill behavior, and payback periods drive the entire model, and none of them show up cleanly on a trailing income statement. Lenders that can’t read those dynamics tend to either pass, or price for uncertainty they haven’t actually diligenced.

For a company growing quickly and looking to acquire, that’s an expensive problem. Direct Meds needed a capital partner that understood how their business actually worked.

A Structure Built Around the Business

Hum’s advanced data analytics gave its underwriting team a deep working understanding of telehealth economics — how acquisition spend converts, how cohorts behave over time, and what the model can genuinely support. 

The result was a $6,000,000 facility built for two jobs at once: funding organic growth while giving the company capital to pursue acquisitions as they arise.

What This Facility Enables

• Growth investment at pace — capital to keep scaling acquisition without slowing to match cash generation
• Acquisition readiness — dollars available when targets surface, rather than a fundraise cycle after the fact
• A capital partner for what’s next — an established relationship to support the company’s next phase of growth

About Direct Meds

Direct Meds is a direct-to-consumer telehealth platform offering prescription treatment programs across weight management, hormone health, sexual health, skin care, hair regrowth, and related categories. Patients complete an online assessment reviewed by a licensed U.S. provider, and approved prescriptions ship from U.S.-licensed pharmacies with ongoing support from a dedicated clinical care team. The company is LegitScript certified and HIPAA compliant, is headquartered in Houston, Texas, and has served more than 250,000 patients.